In this webinar, Steve and Naheed present the latest advances in genomics, the impact on drug target discovery, and how combinatorial analytics is being applied to finding new treatment approaches for patients with unmet medical needs in a wide range of chronic diseases.
Summary
Watch on-demand as PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji, exploring Disease Mechanisms and Novel Target Discovery.
Speakers
Steve Gardner, PhD
CEO & Co-founder of PrecisionLife
Naheed Kurji
Co-Founder/President/CEO at Cyclica Inc.
